Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

POLARx™ Cardiac Cryoablation System Post Market Clinical Study POLAR SMART

NCT05282823 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT05282823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05282823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
POLARx™ Cardiac Cryoablation System Post Market Clinical Study POLAR SMART
Lead sponsor
Boston Scientific Corporation
Phase
Observational
Overall status
Completed
Start date
August 26, 2022
Completion date
October 29, 2024
Enrollment
295 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

paroxysmal atrial fibrillation